Long-term follow-up of a 10-year single-center experience with high-dose pharmacokinetics-directed intravenous busulfan in combination with cyclophosphamide and etoposide as preparative regimen for intermediate- and high-grade non-Hodgkin lymphoma.

Neha R. Patil,Donna Salzman,William P. Vaughan

Long-term follow-up of a 10-year single-center experience with high-dose pharmacokinetics-directed intravenous busulfan in combination with cyclophosphamide and etoposide as preparative regimen for intermediate- and high-grade non-Hodgkin lymphoma.

2014

Neha R. Patil
Donna Salzman
William P. Vaughan

e19521 Background: High dose chemotherapy followed by autologous hematopoietic stem cell transplantation (AHSCT) is indicated for patients with Non-Hodgkin Lymphoma (NHL) recurring after or resista...

Keywords:

Etoposide
Lymphoma
Oncology
Busulfan
Single Center
Pathology
Cyclophosphamide
Internal medicine
Preparative Regimen
Medicine
Pharmacokinetics
Hematopoietic stem cell transplantation
long term follow up

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations